SuO011RANDOMIZED CONTROLLED TRIAL OF MEDIUM CUT-OFF OR HIGH-FLUX DIALYZER ON QUALITY-OF-LIFE OUTCOMES IN MAINTENANCE HEMODIALYSIS PATIENTS

2019 ◽  
Vol 34 (Supplement_1) ◽  
Author(s):  
Jeong-Hoon Lim ◽  
Yeongwoo Park ◽  
Kye Hwa Jeong ◽  
Hee-Yeon Jung ◽  
Ji-Young Choi ◽  
...  
2013 ◽  
Vol 8 (7) ◽  
pp. 1143-1149 ◽  
Author(s):  
Nathan A. Hewitt ◽  
Alicia A. O’Connor ◽  
Denise V. O’Shaughnessy ◽  
Grahame J. Elder

2010 ◽  
Vol 73 (05) ◽  
pp. 374-380 ◽  
Author(s):  
H.C. Park ◽  
H.-B. Yoon ◽  
M.-J. Son ◽  
E.S. Jung ◽  
K.W. Joo ◽  
...  

2002 ◽  
Vol 13 (3) ◽  
pp. 708-714
Author(s):  
Jean-Marc Hurot ◽  
Michel Cucherat ◽  
Margaret Haugh ◽  
Denis Fouque

ABSTRACT. There are many causes for carnitine depletion during maintenance hemodialysis. Supplementation with l-carnitine in animals has been associated with improvement in some abnormalities also present in chronic renal failure. However, it is still controversial whether restoring plasma or tissue carnitine will correct clinical or biologic symptoms observed in maintenance hemodialysis. A systematic review is here performed to determine the effects of l-carnitine in maintenance hemodialysis patients. Eighty-three prospective trials were identified from 1978 to 1999 in which l-carnitine was randomly allocated in 21 trials. Change in serum triglycerides, cholesterol fractions, hemoglobin levels, erythropoietin dose, and other symptoms (muscle function, exercise capacity, and quality of life) were examined. A total of 482 patients in 18 trials were considered for analysis. There was no effect of l-carnitine on triglycerides, total cholesterol, or any of its fractions. Before the erythropoietin (EPO) era, l-carnitine treatment was associated with improved hemoglobin (P < 0.01) and with a decreased EPO dose (P < 0.01) and improved resistance to EPO when patients routinely received EPO. Muscle function, exercise capacity, and quality of life could not be reliably assessed because of the noncombinable nature of end points and the limited number of trials. In conclusion, l-carnitine cannot be recommended for treating the dyslipidemia of maintenance hemodialysis patients. By contrast, this review suggests a promising effect of l-carnitine on anemia management. The route of l-carnitine administration should be evaluated because there is no evidence as to the most efficient method of administration in maintenance hemodialysis.


2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e11511-e11511
Author(s):  
Rao M. Raghavendra ◽  
Kodaganur Srinivasachar Gopinath ◽  
B S Srinath ◽  
Shekhar Patil ◽  
P Shashidhara ◽  
...  

e11511 Background: Adherence plays an important role in success of mind body interventions such as yoga. In this study we evaluated the effects of adherence to yoga intervention on psychological and quality of life outcomes. Methods: Adherence to yoga program was assessed in a randomized controlled trial comparing yoga (n=45) vs. supportive therapy in breast cancer patients with stage II and III disease undergoing primary surgery followed by adjuvant radiotherapy and chemotherapy. Subjects were assessed for self reported symptoms and affective states using symptom checklist, Spielberger’s State Trait Anxiety, Becks Depression Inventory and Functional Living Index in cancer for Quality of life following surgery and during radiotherapy and chemotherapy. Adherence was categorized based on number of sessions of yoga practiced at home per week [regular (>5 sessions), not so regular (3-5 sessions), occasionally (upto 2 sessions)].Multiple hierarchical regression analysis was used to examine the variance in the above outcomes explained by independent prognostic variables (age group, clinical stage of cancer, type of surgery, respective baseline psychological outcomes and regularity of practice) in yoga group alone. Model B includes these four variables plus regularity of practice. Results: Regularity of practice emerged as a secondary predictor for symptom severity following surgery (β= 0.38, p=0.007) and primary predictor for depression (β= 0.37, p=0.05) and severity of symptoms (β= 0.42, p=0.04) during radiotherapy and depression(β= 0.35, p=0.05), severity of symptoms (β= 0.45, p=0.03), anxiety trait(β= 0.40, p=0.03) and quality of life (β= -0.61, p=0.001) during chemotherapy. Conclusions: Adherence to mind body interventions such as yoga improves psychological and quality of life outcomes in breast cancer patients undergoing conventional cancer treatment.


Sign in / Sign up

Export Citation Format

Share Document